LifeMine Therapeutics pockets $175m Series
LifeMine Therapeutics Inc., a biopharmaceutical company, has secured $175 million in Series C financing.
LifeMine Therapeutics Inc., a biopharmaceutical company, has secured $175 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination